Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Iris Biotechnologies Inc

+ Add to Watchlist


0.5500 USD 0.00000.00%

As of 20:10:04 ET on 04/22/2015.

Snapshot for Iris Biotechnologies Inc (IRSB)

Open: 0.5500 Day's Range: 0.5500 - 0.5500 Volume: 300
Previous Close: 0.5500 52wk Range: 0.1500 - 4.5000 1-Yr Rtn: -

Stock Chart for IRSB

No chart data available.
  • IRSB:US 0.5500
  • 1D
  • 1M
  • 1Y
Interactive IRSB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IRSB

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0700
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 8.42
Shares Outstanding (M) 15.31
30 Day Average Volume 95
Price/Book (mrq) 131.3943
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IRSB

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IRSB

Iris Biotechnologies, Inc. researches and develops a breast cancer diagnostic kit. The Company develops a nano-biochip gene expression kit and an artificial intelligence system that assist doctors in diagnosing breast cancer and then designing a treatment plan specific to the patient.

Simon S M ChinChairman/Pres/CEO/CFO/SecyRonald Mark GemberlingChief Medical Officer
Paul YaswenChief Scientific OfficerJames LeblancVP:Operations
More Company Profile & Key Executives for IRSB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil